ScholarIQanswers from OpenAlex

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases

PaperCitations, authors & open-access status

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases have?

ScholarIQcitation count

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases has 93 citations in the OpenAlex counts ScholarIQ stores.

When was Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases published?

ScholarIQyear

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases has 2019 year in the ScholarIQ index.

What is the open-access status of Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases?

ScholarIQoa status

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases has closed oa status in the ScholarIQ index.

What is the DOI of Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases?

ScholarIQdoi

The DOI for Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases is on the source record.

What is the PMID of Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases?

ScholarIQpmid

The PMID for Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases is on the source record.

What is the OpenAlex record for Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases?

ScholarIQopenalex

The OpenAlex for Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial